{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:03:57Z","timestamp":1780581837112,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.psc.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T16:21:20Z","timestamp":1678897280000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Psychotherapy in the Management of Treatment-Resistant Depression"],"prefix":"10.1016","volume":"46","author":[{"given":"Taylor","family":"Rogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cct.2018.12.009","article-title":"ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with treatment-resistant depression: the ELEKT-D study protocol","volume":"77","author":"Mathew","year":"2019","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2023.02.006_bib3","unstructured":"Gordon, J.A., One Year In: COVID-19 and Mental Health. National Institute of Mental Health blog, 2021. Available at: https:\/\/www.nimh.nih.gov\/about\/director\/messages\/2021\/one-year-in-covid-19-and-mental-health."},{"issue":"1","key":"10.1016\/j.psc.2023.02.006_bib4","first-page":"52","article-title":"Computer-assisted cognitive behavior therapy to prevent relapse following electroconvulsive therapy","volume":"33","author":"Wilkinson","year":"2017","journal-title":"J\u00a0ECT"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4088\/JCP.v63n0810","article-title":"Identification of a claims data \"signature\" and economic consequences for treatment-resistant depression","volume":"63","author":"Corey-Lisle","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4088\/JCP.14l09462","article-title":"Clinical characteristics and management of treatment-resistant depression","volume":"76","author":"Conway","year":"2015","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2008.01.006","article-title":"Serious life events among resistant and non-resistant MDD patients","volume":"110","author":"Amital","year":"2008","journal-title":"J\u00a0Affect Disord"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/appi.prcp.20190001","article-title":"Economic burden of treatment-resistant depression among patients hospitalized for major depressive disorder in the United States","volume":"1","author":"Lin","year":"2019","journal-title":"Psychiatric Research and Clinical Practice"},{"key":"10.1016\/j.psc.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2018.07.020","article-title":"Cognitive behavioral therapy for treatment-resistant depression: a systematic review and meta-analysis","volume":"268","author":"Li","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psc.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"101810","DOI":"10.1016\/j.cpr.2019.101810","article-title":"Treating treatment non-responders: a meta-analysis of randomized controlled psychotherapy trials","volume":"75","author":"Gloster","year":"2020","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"10.1016\/j.psc.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tins.2012.12.010","article-title":"Neuronal plasticity and antidepressant actions","volume":"36","author":"Castren","year":"2013","journal-title":"Trends Neurosci"},{"issue":"7","key":"10.1016\/j.psc.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","article-title":"Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression","volume":"72","author":"Cornwell","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"5994","key":"10.1016\/j.psc.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science (New York, N.Y.)."},{"key":"10.1016\/j.psc.2023.02.006_bib16","doi-asserted-by":"crossref","first-page":"110286","DOI":"10.1016\/j.pnpbp.2021.110286","article-title":"Association of electroconvulsive therapy-induced structural plasticity with clinical remission","volume":"110","author":"Takamiya","year":"2021","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamapsychiatry.2017.1378","article-title":"Association of electroconvulsive therapy with psychiatric readmissions in US hospitals","volume":"74","author":"Slade","year":"2017","journal-title":"JAMA Psychiatr"},{"issue":"9","key":"10.1016\/j.psc.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3928\/02793695-20210816-01","article-title":"Treatment-resistant depression: approaches to treatment","volume":"59","author":"Kverno","year":"2021","journal-title":"J\u00a0Psychosoc Nurs Ment Health Serv"},{"issue":"12","key":"10.1016\/j.psc.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1176\/appi.ajp.2021.21040351","article-title":"Association of ECT With risks of all-cause mortality and suicide in older Medicare patients","volume":"178","author":"Rhee","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/da.23222","article-title":"Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis","volume":"39","author":"Wilkinson","year":"2021","journal-title":"Depress Anxiety"},{"issue":"10","key":"10.1016\/j.psc.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","article-title":"A\u00a0novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2023.02.006_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1176\/appi.ps.201700364","article-title":"Identifying recipients of electroconvulsive therapy: data from privately insured Americans","volume":"69","author":"Wilkinson","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"7","key":"10.1016\/j.psc.2023.02.006_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1176\/appi.ps.202000387","article-title":"Barriers to the implementation of electroconvulsive therapy (ECT): results from a nationwide survey of ECT practitioners","volume":"72","author":"Wilkinson","year":"2021","journal-title":"Psychiatr Serv"},{"issue":"7","key":"10.1016\/j.psc.2023.02.006_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hipo.22573","article-title":"Effect of electroconvulsive seizures on cognitive flexibility","volume":"26","author":"Svensson","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.psc.2023.02.006_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jad.2016.06.059","article-title":"Default mode network coherence in treatment-resistant major depressive disorder during electroconvulsive therapy","volume":"205","author":"Mulders","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.psc.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J\u00a0Psychiatry Res"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.1321399111","article-title":"Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders","volume":"111","author":"Dukart","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.psc.2023.02.006_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopsych.2015.02.029","article-title":"Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression","volume":"79","author":"Joshi","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.02.006_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/acps.12150","article-title":"Hippocampal volume in relation to clinical and cognitive outcome after electroconvulsive therapy in depression","volume":"129","author":"Nordanskog","year":"2014","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brs.2008.03.001","article-title":"Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy","volume":"1","author":"Sackeim","year":"2008","journal-title":"Brain Stimul"},{"key":"10.1016\/j.psc.2023.02.006_bib32","doi-asserted-by":"crossref","first-page":"723977","DOI":"10.3389\/fpsyg.2021.723977","article-title":"EffECTively treating depression: a pilot study examining manualized group CBT as follow-up treatment after ECT","volume":"12","author":"Carstens","year":"2021","journal-title":"Front Psychol"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib33","first-page":"196","article-title":"Can cognitive behavioral therapy reduce relapse rates of depression after ECT? A preliminary study","volume":"22","author":"Fenton","year":"2006","journal-title":"J\u00a0ECT"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopsych.2013.11.030","article-title":"Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial","volume":"76","author":"Brakemeier","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.02.006_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2023.02.006_bib36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.02.006_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"16","key":"10.1016\/j.psc.2023.02.006_bib38","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.psc.2023.02.006_bib39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.ajp.21111086","article-title":"An update on community ketamine practices","volume":"179","author":"O'Brien","year":"2022","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.psc.2023.02.006_bib40","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response, [published online ahead of print, 2013 Sep.]","author":"Murrough","year":"2013","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib41","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.psc.2023.02.006_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fpsyt.2014.00149","article-title":"Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation","volume":"5","author":"Morgan","year":"2014","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2023.02.006_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.psc.2023.02.006_bib45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psc.2023.02.006_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145709000169","article-title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","volume":"13","author":"Mathew","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.psc.2023.02.006_bib47","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41386-019-0365-0","article-title":"Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial","volume":"44","author":"Costi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2023.02.006_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","article-title":"Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression","volume":"155","author":"Shiroma","year":"2014","journal-title":"J\u00a0Affect Disord"},{"issue":"5","key":"10.1016\/j.psc.2023.02.006_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother Psychosom"},{"issue":"12","key":"10.1016\/j.psc.2023.02.006_bib50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2023.02.006_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","article-title":"Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial","volume":"67","author":"George","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2023.02.006_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/wps.20199","article-title":"Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial","volume":"14","author":"Levkovitz","year":"2015","journal-title":"World Psychiatr"},{"issue":"11","key":"10.1016\/j.psc.2023.02.006_bib53","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial","volume":"62","author":"O'Reardon","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.02.006_bib54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/npp.2012.237","article-title":"Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials","volume":"38","author":"Berlim","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2016.3644","article-title":"Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis","volume":"74","author":"Brunoni","year":"2017","journal-title":"JAMA Psychiatr"},{"issue":"12","key":"10.1016\/j.psc.2023.02.006_bib56","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4088\/JCP.13m08977","article-title":"A\u00a0multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period","volume":"75","author":"Dunner","year":"2014","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.brs.2017.11.004","article-title":"Simultaneous rTMS and psychotherapy in major depressive disorder: clinical outcomes and predictors from a large naturalistic study","volume":"11","author":"Donse","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1016\/j.psc.2023.02.006_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jad.2017.12.046","article-title":"Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial","volume":"229","author":"Kozel","year":"2018","journal-title":"J\u00a0Affect Disord"},{"issue":"1","key":"10.1016\/j.psc.2023.02.006_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.janxdis.2008.03.015","article-title":"Repetitive TMS combined with exposure therapy for PTSD: a preliminary study","volume":"23","author":"Osuch","year":"2009","journal-title":"J\u00a0Anxiety Disord"},{"issue":"3","key":"10.1016\/j.psc.2023.02.006_bib60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.brs.2012.07.008","article-title":"Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder: a pilot study","volume":"6","author":"Isserles","year":"2013","journal-title":"Brain Stimul"},{"issue":"10","key":"10.1016\/j.psc.2023.02.006_bib61","doi-asserted-by":"crossref","first-page":"e18843","DOI":"10.2196\/18843","article-title":"Repetitive transcranial magnetic stimulation with and without internet-delivered cognitive-behavioral therapy for the treatment of resistant depression: protocol for patient-centered randomized controlled pilot trial","volume":"9","author":"Abou El-Magd","year":"2020","journal-title":"JMIR Res Protoc"},{"issue":"2","key":"10.1016\/j.psc.2023.02.006_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrd3944","article-title":"Beyond magic bullets: true innovation in health care","volume":"12","author":"Narayan","year":"2013","journal-title":"Nat Rev Drug Discov"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X23000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X23000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:41:38Z","timestamp":1759282898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X23000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0193953X23000187"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2023.02.006","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Psychotherapy in the Management of Treatment-Resistant Depression","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}